
Any comparison between intravenous and intracoronary thrombolysis must take into account such elements as the delays imposed by coronary arteriography, the extra cost of the procedure, etc., but ultimately the answer can only be provided by a controlled trial comparing the two approaches. To give truly significant results, this trial should fulfill several requirements concerning the time of randomization to treatments, the procedure to be followed in each group and the criteria of comparison. No such trial is available at present, so that the comparison can only rest on speculations and less demonstrative facts. As it stands, it is not in favour of intracoronary thrombolysis.
Time Factors, Fibrinolytic Agents, Injections, Intra-Arterial, Coronary Thrombosis, Injections, Intravenous, Humans, Coronary Disease, Streptokinase
Time Factors, Fibrinolytic Agents, Injections, Intra-Arterial, Coronary Thrombosis, Injections, Intravenous, Humans, Coronary Disease, Streptokinase
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
